Oral Pill Cures Ebola in Monkeys, Sparking Hope for Human Trials

Researchers have developed an oral pill that cures Ebola in monkeys by targeting the virus’s replication process. This breakthrough, reported alongside similar promising primate studies dating back to 2014 and 2015, is fueling optimism for the pill’s future application in human clinical trials, which are anticipated to begin soon.

Previous reports by outlets such as AP News and BBC News highlighted experimental treatments that successfully cleared the virus in primate models. While these studies stressed that human efficacy remains unproven, the current findings lay important groundwork for advancing treatment options as efforts to combat Ebola continue.